Literature DB >> 22957305

Regulation of cancer stem cell activities by tumor-associated macrophages.

Masahisa Jinushi1, Muhammad Baghdadi, Shigeki Chiba, Hironori Yoshiyama.   

Abstract

Recent studies revealed that tumor-associated macrophages play a decisive role in the regulation of tumor progression by manipulating tumor oncogenesis, angiogenesis and immune functions within tumor microenvironments. However, the role of cancer stem cells in the tumorigenic activities of tumor-associated macrophages during the course of transformation and treatment remains largely unknown. Recent studies have clarified the functional aspects of tumor-associated macrophages in the regulation of the tumorigenic activities and anticancer drug responsiveness of cancer stem cells through complex networks formed by distinct sets of cytokines, chemokines and growth factors. In this article we discuss recent advances and future perspectives regarding the molecular interplay between cancer stem cells and tumor-associated macrophages and provide future perspective about the therapeutic implication against treatment-resistant variants of cancer.

Entities:  

Keywords:  Cancer stem cells; IL-6; M-CSF; MFG-E8; TIM-3; tumor associated macrophages; tumor microenvironments

Year:  2012        PMID: 22957305      PMCID: PMC3433107     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  81 in total

1.  CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

Authors:  Siddhartha Jaiswal; Catriona H M Jamieson; Wendy W Pang; Christopher Y Park; Mark P Chao; Ravindra Majeti; David Traver; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

2.  DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.

Authors:  Timothy Hoey; Wan-Ching Yen; Fumiko Axelrod; Jesspreet Basi; Lucas Donigian; Scott Dylla; Maureen Fitch-Bruhns; Sasha Lazetic; In-Kyung Park; Aaron Sato; Sanjeev Satyal; Xinhao Wang; Michael F Clarke; John Lewicki; Austin Gurney
Journal:  Cell Stem Cell       Date:  2009-08-07       Impact factor: 24.633

3.  High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors.

Authors:  Laureen S Ojalvo; William King; Dianne Cox; Jeffrey W Pollard
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

4.  CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

Authors:  Ravindra Majeti; Mark P Chao; Ash A Alizadeh; Wendy W Pang; Siddhartha Jaiswal; Kenneth D Gibbs; Nico van Rooijen; Irving L Weissman
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

5.  Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation.

Authors:  Masafumi Nakayama; Hisaya Akiba; Kazuyoshi Takeda; Yuko Kojima; Masaaki Hashiguchi; Miyuki Azuma; Hideo Yagita; Ko Okumura
Journal:  Blood       Date:  2009-02-17       Impact factor: 22.113

6.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Authors:  Sunhwa Kim; Hiroyuki Takahashi; Wan-Wan Lin; Pascal Descargues; Sergei Grivennikov; Youngjun Kim; Jun-Li Luo; Michael Karin
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

7.  Identification of selective inhibitors of cancer stem cells by high-throughput screening.

Authors:  Piyush B Gupta; Tamer T Onder; Robert A Weinberg; Eric S Lander; Guozhi Jiang; Kai Tao; Charlotte Kuperwasser
Journal:  Cell       Date:  2009-08-13       Impact factor: 41.582

8.  Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia.

Authors:  Chen Zhao; Alan Chen; Catriona H Jamieson; Mark Fereshteh; Annelie Abrahamsson; Jordan Blum; Hyog Young Kwon; Jynho Kim; John P Chute; David Rizzieri; Michael Munchhof; Todd VanArsdale; Philip A Beachy; Tannishtha Reya
Journal:  Nature       Date:  2009-04-09       Impact factor: 49.962

Review 9.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

10.  M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis.

Authors:  Yoshiaki Kubota; Keiyo Takubo; Takatsune Shimizu; Hiroaki Ohno; Kazuo Kishi; Masabumi Shibuya; Hideyuki Saya; Toshio Suda
Journal:  J Exp Med       Date:  2009-04-27       Impact factor: 14.307

View more
  22 in total

1.  Laparoscopic surgery for colorectal cancer is not associated with an increase in the circulating levels of several inflammation-related factors.

Authors:  Antonio Crucitti; Maddalena Corbi; Pasquina Mc Tomaiuolo; Caterina Fanali; Andrea Mazzari; Donatella Lucchetti; Mario Migaldi; Alessandro Sgambato
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages.

Authors:  Courtney A Penn; Kun Yang; Hong Zong; Jae-Young Lim; Alex Cole; Dongli Yang; James Baker; Sascha N Goonewardena; Ronald J Buckanovich
Journal:  Mol Cancer Ther       Date:  2017-11-13       Impact factor: 6.261

3.  Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells.

Authors:  S Mukherjee; A Manna; P Bhattacharjee; M Mazumdar; S Saha; S Chakraborty; D Guha; A Adhikary; D Jana; M Gorain; S A Mukherjee; G C Kundu; D K Sarkar; T Das
Journal:  Oncogene       Date:  2016-02-29       Impact factor: 9.867

4.  VEGFR3 inhibition chemosensitizes ovarian cancer stemlike cells through down-regulation of BRCA1 and BRCA2.

Authors:  Jaeyoung J Lim; Kun Yang; Barbie Taylor-Harding; W Ruprecht Wiedemeyer; Ronald J Buckanovich
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

Review 5.  Balancing the innate immune system in tumor development.

Authors:  Catharina Hagerling; Amy-Jo Casbon; Zena Werb
Journal:  Trends Cell Biol       Date:  2014-11-28       Impact factor: 20.808

6.  Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression.

Authors:  Chao-Qun Wang; Hao-Ting Sun; Xiao-Mei Gao; Ning Ren; Yuan-Yuan Sheng; Zheng Wang; Yan Zheng; Jin-Wang Wei; Kai-Li Zhang; Xin-Xin Yu; Yin Zhu; Qin Luo; Lu-Yu Yang; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

7.  On the origin and destination of cancer stem cells: a conceptual evaluation.

Authors:  Anja van de Stolpe
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

Review 8.  The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.

Authors:  Jun Ye; Dang Wu; Pin Wu; Zhigang Chen; Jian Huang
Journal:  Tumour Biol       Date:  2014-01-14

Review 9.  Role of the microenvironment in ovarian cancer stem cell maintenance.

Authors:  Jennifer Pasquier; Arash Rafii
Journal:  Biomed Res Int       Date:  2012-12-24       Impact factor: 3.411

10.  VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2.

Authors:  Chengshi Xu; Xing Wu; Jianhong Zhu
Journal:  ScientificWorldJournal       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.